[PDF] Top 20 SISTEMA DE GESTION DE SEGURIDAD Y SALUD LABORAL Tarea 5 iacc
Has 10000 "SISTEMA DE GESTION DE SEGURIDAD Y SALUD LABORAL Tarea 5 iacc" found on our website. Below are the top 20 most common "SISTEMA DE GESTION DE SEGURIDAD Y SALUD LABORAL Tarea 5 iacc".
Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm
... improved as a result of increasing awareness and the publication of diagnostic recommendations by the American Thoracic Society (ATS)/European Respiratory Society (ERS). Nevertheless, the condition remains substantially ... See full document
209
<p>Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology</p>
... based algorithm, we were able simultaneously identify 14 mutations in SERPINA1 gene (instead of two- S and Z-by using our old ...software algorithm that converts the allelic var- iant genotypes into ... See full document
16
α1-Antitrypsin deficiency and chronic respiratory disorders
... or current smokers of any protein phenotype, or in patients with hepatic ...to improve the diagnosis and evaluation of the response to therapy and to develop genetic and regenerative therapies and other ... See full document
14
Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency
... To improve this situation we started an awareness campaign based upon the Polish Respiratory Society National guidelines which were published in 2010 ...explaining how to screen for AATD and the relative ... See full document
41
Regulation of Autophagy by α1-Antitrypsin: “A Foe of a Foe Is a Friend”
... Autophagy is involved in both the cell protective and the cell death process but its mechanism is largely unknown. The pres- ent work unravels a novel intracellular mechanism by which the serpin α 1 -antitrypsin ... See full document
12
Alpha-1 antitrypsin deficiency
... -1 antitrypsin leaves the endoplasmic reticulum and travels by Golgi and secretory vesicles to the plasma membrane, where it is secreted as a 55 kDa glycoprotein at a rate of approximately 34 ...-1 ... See full document
40
A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha 1 antitrypsin deficiency and non alpha 1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
... included five specimens from alpha-1 antitrypsin defi- ciency (AATD) and 34 from non-AATD patients. PCR examinations were conducted on six AATD and 31 non- AATD specimens. History showed a status of cigarette ... See full document
7
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
... Alpha-1 antitrypsin (AAT) is the most abundant serine protease inhibitor circulating in the ...AAT deficiency (AATD) is an autosomal codominant condition affecting an estimated ...alpha-1 antitrypsin ... See full document
7
Relation of serum α -1 antitrypsin (aat) with low grade chronic inflammation in pathogenesis in diabetes mellitus
... circulating α1 antitrypsin (AAT) in freshly diagnosed type 1 (T-1), freshly diagnosed type 2(T-2) as well as type 2 diabetic patients under oral hypoglycemic drugs for duration of at least five ... See full document
24
Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Associated with Alpha-1-Proteinase Inhibitor
... conducted by the National Heart Lung and Blood institute (NHLBI) AATD Registry Group. The most frequent reported side effects include headache, dizziness, nausea, and dyspnea [5]. Although acute allergic reactions, ... See full document
7
In silico assessment of potential druggable pockets on the surface of α1 Antitrypsin conformers
... Induced fit docking. A small number of molecules were selected for induced fit docking (IFD). All these molecules had shown promising Glide SP scores in preliminary docking trials, but some had poor scores following the ... See full document
17
Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
... Involvement of large vessels is uncommon in AAV, while extracranial GCA has been commonly observed in patients with cranial GCA [7]. In this patient with a type B aortic dissection and recent MPO-AAV, a more generalized ... See full document
8
The prevalence of alpha 1 antitrypsin deficiency in Ireland
... The SERPINA1 gene is highly pleiomorphic with over 100 alleles identified to date [9]. Mutations which confer an increased risk of developing pulmonary emphysema and/or liver disease are those in which deficiency ... See full document
76
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
... Results: In all, 7,296 studies were retrieved from searches; 52 trials with 5,632 participants met the inclusion criteria, of which 26 studies involved alpha-1 antitrypsin augmentation and 17 concerned surgical ... See full document
6
Therapeutic target site variability in α1 antitrypsin characterized at high resolution
... antitrypsin. The increased detail provides insight into the mechanism of -sheet A expansion by delineating the hydration of a relatively hydrophobic environment around the highly conserved Trp194 residue, ... See full document
16
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases
... Additionally, TJP2 and MYO5B have been found to cause PFIC. TJP2 is an important component of tight junc- tions, and a deficiency of TJP2 disrupts the tight-junction structure in the liver [56]. MYO5B is ... See full document
170
Expanding the Clinical Indications for α1-Antitrypsin Therapy
... How are T cells affected by AAT without being direct cellular targets? Innate cells appear to undergo marked changes in the presence of added AAT. Neutrophils, in particular, are disarmed (40,42,69). In fact, the ... See full document
17
Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy
... (AAT) can reverse the biochemical deficiencies in serum and lung fluid that characterise emphysema, augmentation therapy has become the cornerstone of patient management. This article, with a focus on experience gained ... See full document
71
α1 Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy
... by strand 2A and helices C and D. The pocket is patent in the native protein but is filled as β-sheet A accepts an exogenous reactive loop peptide during polymerization (29). Agents that can bind to this pocket will ... See full document
26
Deficiency of the Chemotactic Factor Inactivator in Human Sera with α1 Antitrypsin Deficiency
... deficiency of the chemotactic factor inactivator. When normal human serum and a 1 -AT- deficient human sera are chemotactically activated by incubation with immune precipitates, substantially more chemotactic ... See full document
103
Related subjects